Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03452813 · ClinicalTrials.gov registry record
Transitions of Care Stroke Disparity Study (TCSD-S)
A clinical trial, sponsored by University of Miami.
- Completed
- Registry status
- 1,549
- Enrollment target
NCT03452813: Completed study, sponsored by University of Miami.
NCT03452813 is a clinical trial that has completed, run by University of Miami. The registered enrollment target is 1,549 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03452813 has completed, sponsored by University of Miami.
- COMPLETED
- Registry status
- 1,549 participants
- Enrollment target
Study Summary
The TCSD Study will identify disparities in transitions of stroke care and key factors associated with effective transitions of care through structured telephone interviews to evaluate medication adherence, healthy lifestyle, utilization of rehabilitation interventions and medical follow-up 30 days after hospital discharge to home in 2,400 participants across 12 comprehensive stroke centers (CSC) in Florida. A novel Transitions of Stroke Care Performance Index (TOSC PI) correlated with 90-day rehospitalization will be derived and validated.
Primary Outcome
Transitions of Stroke Care Performance Index (TOSC-PI) is a novel score that will be developed based on the results of this study to predict effective transitions of care, and will be composite score that includes medication and lifestyle adherence, diet, tobacco and alcohol cessation, exercise, utilization of rehabilitation services, and medical follow-up after discharge. The index will be calculated as the points achieved over the total for which the participant is eligible. High scores indica
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,549 participants |
| Start Date | 2018-06-01 |
| Est. Completion | 2023-12-11 |
What the finished NCT03452813 record still lists
NCT03452813 is an observational study that tracks outcomes without assigning an intervention. Its 1,549 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT03452813 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03452813 about?
NCT03452813 is a clinical study titled "Transitions of Care Stroke Disparity Study (TCSD-S)". The TCSD Study will identify disparities in transitions of stroke care and key factors associated with effective transitions of care through structured telephone interviews to evaluate medication adherence, healthy lifestyle, utilization of rehabilitation interventions and medical follow-up 30 days ...
What is the current status of trial NCT03452813?
This trial is currently completed. The enrollment target is 1,549 participants. The study started on 2018-06-01. Estimated completion is 2023-12-11.
Who is sponsoring clinical trial NCT03452813?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02650622 · 1,550 participants
Genetic and Metabolic Disease in Children
- NCT03961945 · 1,550 participants · NA
Minimally Invasive Molecular Approaches for the Diagnosis of Barrett's Esophagus and Esophageal Adenocarcinoma
- NCT06729775 · 1,546 participants · NA
Disentangling the Role of Culture, Life Stage, and Information Design to Facilitate Equity in Data Report Back
- NCT03435796 · 1,541 participants · Phase 2
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI